These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis. Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Yoshifuji H Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262 [TBL] [Abstract][Full Text] [Related]
12. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases. Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427 [TBL] [Abstract][Full Text] [Related]
13. The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis. Conticini E; Sota J; Falsetti P; Baldi C; Bardelli M; Bellisai F; Tosi GM; Frediani B; Cantarini L Mediators Inflamm; 2020; 2020():3203241. PubMed ID: 33061825 [TBL] [Abstract][Full Text] [Related]
14. Tocilizumab for the treatment of giant cell arteritis. Schirmer M; Muratore F; Salvarani C Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of tocilizumab for intractable Takayasu arteritis and Isobe M; Maejima Y; Saji M; Tateishi U J Cardiol; 2021 May; 77(5):539-544. PubMed ID: 33451862 [TBL] [Abstract][Full Text] [Related]
16. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis. Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209 [TBL] [Abstract][Full Text] [Related]
17. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review. Decker P; Olivier P; Risse J; Zuily S; Wahl D Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826 [TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center. Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool. Sebastian A; Kayani A; Prieto-Pena D; Tomelleri A; Whitlock M; Mo J; van der Geest N; Dasgupta B RMD Open; 2020 Nov; 6(3):. PubMed ID: 33161376 [TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]